Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.
about
Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neuronsCurrent and future uses of neuroimaging for cognitively impaired patients.Unveiling molecular events in the brain by noninvasive imaging.Differential effects of acetylcholinesterase inhibitors on clinical responses and cerebral blood flow changes in patients with Alzheimer's disease: a 12-month, randomized, and open-label trialPotential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer's disease.Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive ImpairmentA review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.Symptomatic treatment of Alzheimer's disease: identification of biomarkers to aid translation from bench to bedside.Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease.Retinal manifestations of Alzheimer's disease.The development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous system.Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease.A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease.rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.
P2860
Q28479242-15C03C3F-C51F-4A82-A5D5-81716E91D955Q31143267-60FAE3B9-1B9A-4229-9942-B0E1642D5798Q34046040-B25740DF-D387-488D-BD1C-D8F84F90C04DQ35631407-6320D2B1-56C2-4585-BF2F-B3F435CCD568Q36571755-2DEA5079-C559-45ED-9E27-875D53CCDE89Q36842150-59C77194-7ACD-4BDB-AD73-60667764ABE7Q36846711-AB3CB3EF-5FA8-4DE4-A55E-317B42A7A2C2Q36908486-1D458C60-02F1-48EC-BCFB-5AD462645847Q37070395-909BE87A-60EA-4F8C-9175-CCEB5F6DDD3EQ37219776-71772F29-D7CF-48BD-907A-2F6A9BB3D656Q37755138-47CD0875-17AA-4865-BD9B-F8663209BF6BQ37985523-63ED1E20-5328-440F-B216-F2C316127DDCQ38037156-FD68B3A1-B646-4089-838F-5DAE13F9B1E6Q38237224-6DE13B7B-F2C4-49F3-87AE-688B131E1F0BQ38907580-806E1979-FD0B-48A3-AEC3-DBD0ABFA94B4Q42656272-236F07F6-9537-4AF2-A192-959977A58464Q42945653-9E79A157-1C8B-4B9F-A6CC-B3BD598BCB0AQ47299480-5CC3FF67-F738-48D2-A272-C8219B011A8CQ48609636-FA49F626-B7AF-4569-8D5A-87ED6758316C
P2860
Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Longitudinal PET evaluation of ...... with mild Alzheimer's disease.
@en
Longitudinal PET evaluation of ...... with mild Alzheimer's disease.
@nl
type
label
Longitudinal PET evaluation of ...... with mild Alzheimer's disease.
@en
Longitudinal PET evaluation of ...... with mild Alzheimer's disease.
@nl
prefLabel
Longitudinal PET evaluation of ...... with mild Alzheimer's disease.
@en
Longitudinal PET evaluation of ...... with mild Alzheimer's disease.
@nl
P2093
P2860
P50
P1476
Longitudinal PET evaluation of ...... with mild Alzheimer's disease
@en
P2093
P2860
P2888
P304
P356
10.1007/S00702-005-0312-6
P577
2005-07-29T00:00:00Z